Apyx Medical Corporation

153 articles with Apyx Medical Corporation

• APYX UPCOMING DEADLINE: Rosen, a Top Ranked Law Firm, Reminds Apyx Medical Corporation Investors of Important Deadline in the Securities Class Action; Encourages Investors with Over $100K in Losses to Contact the Firm - APYX

  6/6/2019

  Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Apyx Medical Corporation from August 1, 2018 through April 1, 2019, inclusive of the important June 17, 2019 deadline in the securities class action.

• Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2018 Financial Results on March 13, 2019

  2/7/2019

  Apyx Medical Corporation announced that financial results for the fourth quarter and fiscal year 2018 will be released after the market closes on Wednesday, March 13.

• Apyx Medical Corporation Announces the Promotion of Todd Hornsby to Executive Vice President

  1/14/2019

  Apyx Medical Corporation, formerly Bovie Medical Corporation, (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of J-Plasma®, a patented surgical product marketed and sold under the Renuvion® Cosmetic Technology brand in the cosmetic surgery market, today announced that Todd Hornsby has been promoted to Executive Vice President, effective January 2, 2019.

• Apyx Medical Corporation Reports Preliminary Full Year and Fourth Quarter 2018 Revenue Results

  1/7/2019

  Advanced Energy Sales of approximately $4.4 to $4.5 million in Q4, up 43% to 47% year-over-year

• Bovie Medical Corporation Announces Appointment of Tara H. Semb as Chief Financial Officer

  12/17/2018

  Effective January 2, 2019.

• Bovie Medical Corporation Announces Future Retirement of Jay D. Ewers, Chief Financial Officer, Treasurer and Secretary

  11/13/2018

  Bovie Medical Corporation today announced that Jay D. Ewers, Chief Financial Officer, Treasurer and Secretary, intends to retire.

• Bovie Medical Corporation Reports Third Quarter 2018 Financial Results and Updates Fiscal Year 2018 Outlook

  11/1/2018

  Bovie Medical Corporation (NYSEAMERICAN:BVX) (the “Company”), a maker of medical devices and supplies and the developer of J-Plasma®, a patented surgical product marketed and sold under the Renuvion® Cosmetic Technology brand in the cosmetic surgery market, today reported financial results for its third quarter ended September 30, 2018.

• Bovie Medical Corporation to Participate in the 9th Annual Craig-Hallum Alpha Select Conference

  10/31/2018

  Bovie Medical Corporation today announced that management will participate in the 9th Annual Craig-Hallum Alpha Select Conference at the Sheraton New York Times Square Hotel in New York, New York. Management will host one-on-one meetings with investors at the conference on Thursday, November 15.

• Bovie Medical Corporation Announces Appointment of Laura Iversen as Director of Global Operations for Advanced Energy

  10/22/2018

  Bovie Medical is a medical technology company and the developer of J-Plasma®, a patented surgical product marketed and sold under the Renuvion™ Cosmetic Technology brand in the cosmetic surgery market.

• Bovie Medical Corporation to Release Third Quarter of Fiscal Year 2018 Financial Results on November 1, 2018

  10/3/2018

  Bovie Medical (NYSEMKT:BVX), a medical technology company and the developer of J-Plasma®, a patented surgical product marketed and sold under the Renuvion™ Cosmetic Technology brand in the cosmetic surgery market, today announced that financial results for the third quarter of fiscal year 2018 will be released after the market closes on Thursday, November 1.

• Bovie Medical Corporation Updates Fiscal Year 2018 Financial Outlook

  9/5/2018

  Now Expect Advanced Energy Sales Growth of 55% to 60% year-over-year

• Bovie Medical Corporation Announces Completion of “Core” Business Segment Sale to Symmetry Surgical, Inc. for Total Cash Consideration of $97 Million

  8/30/2018

  Bovie Medical Corporation, a maker of medical devices and supplies and the developer of J-Plasma®, a patented surgical product marketed and sold under the Renuvion™ Cosmetic Technology brand in the cosmetic surgery market, today announced that it has completed the previously announced divestiture and sale of the Core business segment and the Bovie® brand to Symmetry Surgical for gross proceeds of $97 million in cash.

• Bovie Medical Corporation Reports Second Quarter 2018 Financial Results

  8/1/2018

  Advanced Energy Sales of $3.1 million in Q2, up 72% year-over-year

• Bovie Medical Corporation to Release Second Quarter of Fiscal Year 2018 Financial Results on August 1, 2018

  7/23/2018

  Bovie Medical announced that financial results for the second quarter of fiscal year 2018 will be released after the market closes on Wednesday, August 1.

• RoundTable Healthcare Partners and Symmetry Surgical Inc. to Acquire Bovie Medical's Electrosurgical Business

  7/9/2018

  Acquisition Enhances Symmetry's Operating Room Product Portfolio; Creates Complete Energy Product Offering

• Bovie Medical Corporation Announces Preliminary Second Quarter 2018 Revenue Results

  7/9/2018

  Advanced Energy Sales increased approximately 70% year-over-year in Q2’18

• Bovie Medical Corporation Announces Agreement to Sell “Core” Business Segment to Symmetry Surgical, Inc. for Total Cash Consideration of $97 million

  7/9/2018

  ​Divestiture and Sale of the Core business segment represents an important strategic transaction that significantly enhances Bovie Medical’s balance sheet and allows the Company to further focus on the commercialization of J-Plasma/Renuvion™ Cosmetic Technology

• Bovie Medical Corporation to Participate in the JMP Securities 2018 Life Science Conference

  5/31/2018

  Bovie Medical Corporation is a leading maker of medical devices and supplies as well as the developer of J-Plasma®

• Bovie Medical Corporation Announces Appointment of Diane I. Duncan, M.D., FACS to Medical Advisory Board

  5/1/2018

  Bovie Medical Corporation announced the appointment of Diane I. Duncan, M.D., FACS to the Company’s Medical Advisory Board.

• Bovie Medical Corporation to Release First Quarter of Fiscal Year 2018 Financial Results on May 14, 2018

  4/27/2018

  Bovie Medical announced that financial results for the first quarter of fiscal year 2018 will be released after the market closes on Monday, May 14.